|
The stacked column chart illustrates the percentage of developing embryos with neural tube defects at 120 hpf in groups exposed to decitabine alone and in the presence of myo-inositol (MI). The percentage of phenotypic outcomes with neural tube defects in group exposed to DCT 1 mM was 100% and in groups exposed to DCT 1 mM + MI 50 µM and DCT 1 mM + MI 100 µM, the percentage of phenotypic outcomes with neural tube defects was found to be 65% and 70% respectively. aValues are significantly different from control at 120 hpf, bValues are significantly different from DCT 1 mM group at 120 hpf. *P<0.05, **P<0.001,***P < 0.0001 (one-way ANOVA followed by Dunnett’s test), n=20
|